252 related articles for article (PubMed ID: 19137883)
21. Potential increase in the prognostic value of p53 mutation by Pro72 allele in stage I non-small-cell lung cancer.
Chien WP; Wong RH; Wu TC; Cheng YW; Chen CY; Lee H
Ann Surg Oncol; 2009 Jul; 16(7):1918-24. PubMed ID: 19434453
[TBL] [Abstract][Full Text] [Related]
22. [Experimental study on p53 gene mutation in keloid fibroblasts].
Liu W; Jiang YH; Li YL; Lin ZH; Jiang H; Tan Q; Zhang JL; Wang ZM
Zhonghua Shao Shang Za Zhi; 2004 Apr; 20(2):85-7. PubMed ID: 15312469
[TBL] [Abstract][Full Text] [Related]
23. [TP53 codon 72 polymorphism and gastric cancer risk: a case-control study in individuals from the central-western region of Venezuela].
Cañas M; Morán Y; Camargo ME; Rivero MB; Bohórquez A; Villegas V; Ramírez E; Rendón Y; Suárez A; Morales L; Useche E; Salazar S; Zambrano A; Ramírez A; Valderrama E; Briceño Z; Chiurillo MA
Invest Clin; 2009 Jun; 50(2):153-61. PubMed ID: 19662811
[TBL] [Abstract][Full Text] [Related]
24. Determination of p53 genotypes in oral cancer patients from India.
Tandle AT; Sanghvi V; Saranath D
Br J Cancer; 2001 Mar; 84(6):739-42. PubMed ID: 11259085
[TBL] [Abstract][Full Text] [Related]
25. Detection of oncogenic viruses SV40, BKV, JCV, HCMV, HPV and p53 codon 72 polymorphism in lung carcinoma.
Giuliani L; Jaxmar T; Casadio C; Gariglio M; Manna A; D'Antonio D; Syrjanen K; Favalli C; Ciotti M
Lung Cancer; 2007 Sep; 57(3):273-81. PubMed ID: 17400331
[TBL] [Abstract][Full Text] [Related]
26. The associations of p53 overexpression with p53 codon 72 genetic polymorphism in esophageal cancer.
Lee JM; Shun CT; Wu MT; Chen YY; Yang SY; Hung HI; Chen JS; Hsu HH; Huang PM; Kuo SW; Lee YC
Mutat Res; 2006 Feb; 594(1-2):181-8. PubMed ID: 16318864
[TBL] [Abstract][Full Text] [Related]
27. The Pro/Pro genotype of the p53 codon 72 polymorphism modulates PAI-1 plasma levels in ageing.
Testa R; Bonfigli AR; Salvioli S; Invidia L; Pierini M; Sirolla C; Marra M; Testa I; Fazioli F; Recchioni R; Marcheselli F; Olivieri F; Lanari L; Franceschi C
Mech Ageing Dev; 2009 Aug; 130(8):497-500. PubMed ID: 19523975
[TBL] [Abstract][Full Text] [Related]
28. p53 codon 72 Pro homozygosity increases the risk of cutaneous melanoma in individuals with dark skin complexion and among noncarriers of melanocortin 1 receptor red hair variants.
Stefanaki I; Stratigos AJ; Dimisianos G; Nikolaou V; Papadopoulos O; Polydorou D; Gogas H; Tsoutsos D; Panagiotou P; Kanavakis E; Antoniou C; Katsambas AD
Br J Dermatol; 2007 Feb; 156(2):357-62. PubMed ID: 17223878
[TBL] [Abstract][Full Text] [Related]
29. Possible association of p53 codon 72 polymorphism with susceptibility to adult and pediatric high-grade astrocytomas.
Parhar P; Ezer R; Shao Y; Allen JC; Miller DC; Newcomb EW
Brain Res Mol Brain Res; 2005 Jun; 137(1-2):98-103. PubMed ID: 15950766
[TBL] [Abstract][Full Text] [Related]
30. p53 gene alterations and human papillomavirus type 16 infection in early stages of cervical carcinoma in Serbia.
Malisic E; Jankovic R; Majkic M; Dobricic J; Radulovic S
J BUON; 2008; 13(4):525-32. PubMed ID: 19145674
[TBL] [Abstract][Full Text] [Related]
31. Association between the TP53 codon72 polymorphism and oral cancer risk and prognosis.
Kuroda Y; Nakao H; Ikemura K; Katoh T
Oral Oncol; 2007 Nov; 43(10):1043-8. PubMed ID: 17306604
[TBL] [Abstract][Full Text] [Related]
32. TP53 codon 72 polymorphism contributes to nasopharyngeal cancer susceptibility: a meta-analysis.
Zhuo XL; Cai L; Xiang ZL; Zhuo WL; Wang Y; Zhang XY
Arch Med Res; 2009 May; 40(4):299-305. PubMed ID: 19608020
[TBL] [Abstract][Full Text] [Related]
33. Association of p53 polymorphism with ICSI/IVF failure and recurrent pregnancy loss.
Firouzabadi RD; Ghasemi N; Rozbahani MA; Tabibnejad N
Aust N Z J Obstet Gynaecol; 2009 Apr; 49(2):216-9. PubMed ID: 19432615
[TBL] [Abstract][Full Text] [Related]
34. Association between TP53 gene ARG72PRO polymorphism and chromosome aberrations in human cancers.
Litviakov NV; Denisov EV; Takhauov RM; Karpov AB; Skobel'skaja EV; Vasil'eva EO; Goncharik OO; Ageeva AM; Mamonova NV; Mezheritskiy SA; Sevost'janova NV; Koshel AP
Mol Carcinog; 2010 Jun; 49(6):521-4. PubMed ID: 20512840
[TBL] [Abstract][Full Text] [Related]
35. Polymorphisms in p53, GSTP1 and XRCC1 predict relapse and survival of gastric cancer patients treated with oxaliplatin-based adjuvant chemotherapy.
Huang ZH; Hua D; Du X
Cancer Chemother Pharmacol; 2009 Oct; 64(5):1001-7. PubMed ID: 19247656
[TBL] [Abstract][Full Text] [Related]
36. p53 codon 72 polymorphism and HPV status in lung cancer.
Buyru N; Altinisik J; Isin M; Dalay N
Med Sci Monit; 2008 Sep; 14(9):CR493-7. PubMed ID: 18758421
[TBL] [Abstract][Full Text] [Related]
37. Influence of the TP53 codon 72 polymorphism on the cellular responses to X-irradiation in fibroblasts from nonagenarians.
den Reijer PM; Maier AB; Westendorp RG; van Heemst D
Mech Ageing Dev; 2008 Apr; 129(4):175-82. PubMed ID: 18272203
[TBL] [Abstract][Full Text] [Related]
38. p53 codon 72 polymorphism, DNA damage and repair, and risk of non-melanoma skin cancer.
Bendesky A; Rosales A; Salazar AM; Sordo M; Peniche J; Ostrosky-Wegman P
Mutat Res; 2007 Jun; 619(1-2):38-44. PubMed ID: 17403527
[TBL] [Abstract][Full Text] [Related]
39. No relationship observed between human p53 codon-72 genotype and HPV-associated cervical cancer in a population group with a low arginine-72 allele frequency.
Govan VA; Loubser S; Saleh D; Hoffman M; Williamson AL
Int J Immunogenet; 2007 Jun; 34(3):213-7. PubMed ID: 17504512
[TBL] [Abstract][Full Text] [Related]
40. The TP53 codon 72 polymorphism and predisposition to adrenocortical cancer in Polish patients.
Ignaszak-Szczepaniak M; Horst-Sikorska W; Sawicka J; Kaczmarek M; Slomski R
Oncol Rep; 2006 Jul; 16(1):65-71. PubMed ID: 16786124
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
